USAIC Panel 2026: AI in BioPharma R&D – Hype vs. Reality
USAIC
0:00 / 0:00
USAIC Panel 2026: AI in BioPharma R&D – Hype vs. Reality
51 просмотр · 11 дн. назад
USAIC
145 подписчиков
51 просмотр · 11 дн. назад
Panel: AI in BioPharma R&D – Hype vs. Reality
Panelists:
Dr. Dina Katabi, Professor of Computer Science, MIT
Gianluca Pettiti, President and Chief Operating Officer, Thermo Fisher Scientific
Dr. Jason Kelly, Co-Founder & CEO, Ginkgo Bioworks
Dr. Justine Rochon, Senior Vice President, R&D Data and Quantitative Science, Takeda
Dr. Paul Burton, Chief Medical Officer, Amgen
Moderator:
Sastry Chilukuri, Chairman & CEO, Emmes Group